Ziprasidone Mesylate Patent Expiration
Ziprasidone Mesylate is Used for managing symptoms of bipolar disorder, neuroleptic diseases, and psychosis. It was first introduced by Viatris Specialty Llc
Ziprasidone Mesylate Patents
Given below is the list of patents protecting Ziprasidone Mesylate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Geodon | US6232304 | Inclusion complexes of aryl-heterocyclic salts |
Apr 01, 2017
(Expired) | Viatris |
| Geodon | US6399777 | Inclusion complexes of aryl-heterocyclic salts |
Apr 01, 2017
(Expired) | Viatris |
| Geodon | US6110918 | Mesylate trihydrate salt of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihy dro-2(1H)-indol-2-one (=ziprasidone), its preparation and its use as dopamine D2 antagonist |
Mar 26, 2017
(Expired) | Viatris |
Ziprasidone Mesylate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List